Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kisqali
Pharma
Novartis halts recruitment of trials for cancer drug Kisqali
Novartis has paused the enrollment of patients in clinical trials of breast cancer drug Kisqali as it adjusts its manufacturing processes.
Kevin Dunleavy
Apr 10, 2024 11:09am
FDA chides Novartis for ‘false or misleading’ Kisqali TV spot
Jan 23, 2024 8:46am
SABCS: Novartis gives update on Kisqali in early breast cancer
Dec 8, 2023 9:15am
Lilly's Verzenio barely misses overall survival goal in 1L
Dec 6, 2023 10:00am
Novartis puts Kisqali's peak sales potential at above $7B
Nov 28, 2023 10:48am
Novartis delays Pluvicto filing as CEO spots industry conundrum
Oct 24, 2023 10:22am